-
effectivehealthcare.ahrq.gov/health-topics/congenital-heart-defects
-
effectivehealthcare.ahrq.gov/get-involved/nominated-topics/can-screening-among-the-general-adult-male-population-for-elevated-pca3-also-known-as-dd3-gene-expression-to-identify-those-at-risk-for-prostate-cancer-who-may-be-candidates-for-prostate-biopsy-reduce-morbidity-and-mortality
-
effectivehealthcare.ahrq.gov/products/grades-predictive-values/white-paper-2015
-
effectivehealthcare.ahrq.gov/products/methods-quantitative-synthesis-update/methods
-
effectivehealthcare.ahrq.gov/products/insomnia/research
-
effectivehealthcare.ahrq.gov/health-topics/down-syndrome
-
effectivehealthcare.ahrq.gov/health-topics/brachial-plexus-injuries
-
effectivehealthcare.ahrq.gov/products/ems-blood-transfusion/protocol
-
effectivehealthcare.ahrq.gov/health-topics/infertility
-
effectivehealthcare.ahrq.gov/health-topics/esophageal-cancer
-
effectivehealthcare.ahrq.gov/health-topics/sarcoidosis
-
effectivehealthcare.ahrq.gov/sites/default/files/pdf/labor-nitrous-oxide_research-protocol.pdf
August 24, 2011 - informed by clinical expertise, lists of potential
confounders and effect modifiers (e.g., simultaneous therapies … We will also
review potential modifiers of effect of treatment, which may include different age groups
-
effectivehealthcare.ahrq.gov/sites/default/files/calcineurin-inhibitor_disposition-comments.pdf
March 15, 2016 - general
have shown the same outcomes regardless of agent,
i.e. increased rejection, but to be fair on treatment … Immunosuppressive
regimens for transplant
recipients are guided by
therapeutic drug monitoring
(TDM … Long-term evaluation of analytical methods
used in sirolimus therapeutic drug monitoring. … ("Thirty-six studies of low-dose CNI treatment provided
high strength evidence that minimization was … Was it the low dose calcineurin or the induction
therapy?
-
effectivehealthcare.ahrq.gov/sites/default/files/related_files/cancer-ovarian-contraceptives_executive.pdf
June 01, 2013 - highest incidence (60 years and older).2
While advances in surgery, chemotherapy,
and radiation therapy … research agenda and
clinical recommendations, as evidenced by the experience
with hormone replacement therapy … in preventing
unintended pregnancies; the potential effectiveness of OCs
as primary or adjunctive treatments … with the target population, version or
characteristics of the intervention used in comparison with
therapies … be reassuring to women considering
OCs for contraception and to women who are prescribed
OCs for treatment
-
effectivehealthcare.ahrq.gov/sites/default/files/related_files/public-reporting-quality-improvement_disposition-comments.pdf
July 26, 2012 - Peer Reviewer 3 Methods Similar questions arise in regard to the use of criteria regarding “true
treatment … For this review treatment
effect is interpreted as the impact of public
reporting regardless of the
-
effectivehealthcare.ahrq.gov/products/c-difficile-update/research-protocol
-
effectivehealthcare.ahrq.gov/products/disruptive-behavior-disorder/clinician
-
effectivehealthcare.ahrq.gov/products/liver-cancer/research
-
effectivehealthcare.ahrq.gov/health-topics/cancer-immunotherapy
-
effectivehealthcare.ahrq.gov/products/adhd-update/research-protocol